Immune reconstitution inflammatory syndrome in natalizumab-associated PML

OBJECTIVE: To study the outcome of patients with multiple sclerosis (MS) and with natalizumab-associated progressive multifocal leukoencephalopathy (PML) and immune reconstitution inflammatory syndrome (IRIS). METHODS: MedWatch reports from Biogen-Idec (manufacturer of natalizumab, Tysabri(®)) were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tan, I.L., McArthur, J.C., Clifford, D.B., Major, E.O., Nath, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2011
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3174071/
https://ncbi.nlm.nih.gov/pubmed/21832229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31822e55e7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados